Search clinical trials for: Relapsed / refractory multiple myeloma
Total 21553 results
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple Myeloma
-
ChimerixActive, not recruiting
-
Bristol-Myers SquibbAbbVie; CelgeneCompletedMultiple MyelomaUnited States, Germany, Italy, Greece, Netherlands, Australia, Spain, Poland, Canada, France, Japan
-
CelgeneCompletedMultiple MyelomaBelgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
TakedaCompleted
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Johnson & Johnson Private LimitedCompleted
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
PETHEMA FoundationCelgene Corporation; Array BioPharmaCompleted
-
Hackensack Meridian HealthGenentech, Inc.TerminatedA Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Thomas Martin, MDWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
CelgeneCompleted
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
University of LeedsCelgene; Myeloma UKActive, not recruitingMultiple MyelomaUnited Kingdom
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
University of Heidelberg Medical CenterGerman Cancer Research Center; University Hospital Heidelberg; Array BioPharma; Coordinating Centre for Clinical Trials HeidelbergActive, not recruitingRelapsed or Refractory Multiple Myeloma | Patients With BRAFV600 E or BRAFV600K MutationGermany
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
Sorrento Therapeutics, Inc.CompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Corvus Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
CelgeneCompletedMultiple MyelomaUnited States
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
Qilu Pharmaceutical Co., Ltd.Active, not recruitingMultiple Myeloma | Recurrent or RefractoryChina
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
ItalfarmacoTerminatedMultiple MyelomaItaly
-
AbbVieSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia (AML)United States, Germany, United Kingdom
-
Washington University School of MedicineJanssen, LPWithdrawn
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminated
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
Oncopeptides ABWithdrawnMultiple Myeloma | Relapse Multiple MyelomaCzechia
-
MorphoSys AGCompletedMultiple MyelomaAustria, Germany
-
Weijun FuNanjing Legend Biotech Co.Active, not recruiting
-
AstraZenecaCompletedAcute Myeloid Leukemia | Multiple Myeloma | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | High Risk Myelodysplastic Syndrome | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin Lymphoma | Richter's Syndrome | T-cell Non-Hodgkin Lymphoma | Relapsed or Refractory...United Kingdom, Germany, Netherlands